88 related articles for article (PubMed ID: 369688)
1. Phase II study of nafoxidine in the therapy for advanced renal carcinoma.
Feun LG; Drelichman A; Singhakowinta A; Vaitkevicius VK; Oishi N
Cancer Treat Rep; 1979 Jan; 63(1):149-50. PubMed ID: 369688
[No Abstract] [Full Text] [Related]
2. Therapeutic value of nafoxidine hydrochloride in the treatment of advanced carcinoma of the human breast.
Sasaki GH; Leung BS; Fletcher WS
Surg Gynecol Obstet; 1976 Apr; 142(4):560-4. PubMed ID: 1257870
[TBL] [Abstract][Full Text] [Related]
3. Nafoxidine--an antiestrogen for the treatment of breast cancer.
Legha SS; Slavik M; Carter SK
Cancer; 1976 Oct; 38(4):1535-41. PubMed ID: 991075
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of tamoxifen in patients with advanced renal cell carcinoma.
Glick JH; Wein A; Torri S; Alavi J; Harris D; Brodovsky H
Cancer Treat Rep; 1980; 64(2-3):343-4. PubMed ID: 7407768
[No Abstract] [Full Text] [Related]
5. Clinical trial of nafoxidine in advanced breast cancer.
Steinbaum FL; De Jager RL; Krakoff IH
Med Pediatr Oncol; 1978; 4(2):123-6. PubMed ID: 661750
[TBL] [Abstract][Full Text] [Related]
6. Therapy with nafoxidine for patients suffering from postmenopausal ulcerated mammary cancer.
Bumma C; Gino GC; Calciati A; La Grotta G; Gallo G; Falda M
Panminerva Med; 1976; 18(3-4):137-41. PubMed ID: 1256902
[No Abstract] [Full Text] [Related]
7. Phase II evaluation of chlorozotocin in patients with renal cell carcinoma.
Gralla RJ; Yagoda A
Cancer Treat Rep; 1979 Jun; 63(6):1007-8. PubMed ID: 157222
[No Abstract] [Full Text] [Related]
8. Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine.
Stolbach LL; Begg CB; Hall T; Horton J
Cancer Treat Rep; 1981; 65(7-8):689-92. PubMed ID: 6454485
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature.
Weiselberg L; Budman D; Vinciguerra V; Schulman P; Degnan TJ
Cancer Clin Trials; 1981; 4(2):195-8. PubMed ID: 7249256
[TBL] [Abstract][Full Text] [Related]
10. Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
Gams RA; Nelson O; Birch R
Cancer Treat Rep; 1986 Jul; 70(7):921-2. PubMed ID: 3521848
[No Abstract] [Full Text] [Related]
11. [Treatment of breast cancers with antiestrogens. Clinical study of nafoxidine].
Metz R; Bey P
Nouv Presse Med; 1977 Dec; 6(44):4145-6. PubMed ID: 600772
[No Abstract] [Full Text] [Related]
12. Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
Hahn RG; Bauer M; Wolter J; Creech R; Bennett JM; Wampler G
Cancer Treat Rep; 1979 Mar; 63(3):513-5. PubMed ID: 371804
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of nafoxidine in adrenalectomized patients with advanced breast cancer.
Jain J; Samal B; Singhakowinta A; Vaitkevicius VK
Cancer; 1977 Nov; 40(5):2063-6. PubMed ID: 336179
[TBL] [Abstract][Full Text] [Related]
14. Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.
Heuson JC; Engelsman E; Blonk-Van Der Wijst J; Maass H; Drochmans A; Michel J; Nowakowski H; Gorins A
Br Med J; 1975 Jun; 2(5973):711-3. PubMed ID: 1095121
[TBL] [Abstract][Full Text] [Related]
15. Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma.
Evans WK; Shepherd FA; Blackstein ME; Osoba D; Taylor D
Cancer Treat Rep; 1985 Jun; 69(6):727-8. PubMed ID: 4016779
[No Abstract] [Full Text] [Related]
16. Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
Wong PP; Yagoda A; Currie VE; Young CW
Cancer Treat Rep; 1977 Dec; 61(9):1727-9. PubMed ID: 340038
[No Abstract] [Full Text] [Related]
17. Phase II trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study.
Schulman P; Davis RB; Rafla S; Green M; Henderson E
Cancer Treat Rep; 1984 Oct; 68(10):1305-6. PubMed ID: 6525606
[No Abstract] [Full Text] [Related]
18. Phase II study of medroxyprogesterone acetate with tamoxifen in advanced renal cell cancer.
Fuks JZ; Aisner J; Van Echo DA; Wiernik PH
Cancer Treat Rep; 1982 Sep; 66(9):1773-4. PubMed ID: 7116354
[No Abstract] [Full Text] [Related]
19. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
[No Abstract] [Full Text] [Related]
20. Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study.
Ratanatharathorn V; Baker LH; Balducci L; Talley RW; Hoogstraten B
Cancer Treat Rep; 1982 May; 66(5):1231-2. PubMed ID: 7083224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
